Papers
1
Total Citations
6
H-Index
1
About
Ryan Vargo is a translational pharmacologist whose research focuses on developing innovative strategies to eradicate latent HIV infection, a critical barrier to curing the disease. His work centers on pharmacokinetic/pharmacodynamic (PK/PD) modeling and the use of automated platforms to evaluate novel latency-reversing agents. In his highly cited 2021 study, Vargo pioneered an in vitro PK/PD modeling approach to assess the efficacy of novel histone deacetylase inhibitors (HDACis) in reversing HIV latency, demonstrating how automated systems can accelerate the screening of potential therapeutics. This work has garnered significant attention, with 6 citations, and represents a key contribution to the field of HIV cure research by providing a reproducible, high-throughput method to quantify drug effects on latent reservoirs. Vargo’s integration of pharmacology and virology offers a powerful framework for identifying compounds that could ultimately enable the elimination of persistent HIV, moving beyond suppressive antiretroviral therapy. His research is particularly impactful for students and researchers interested in the intersection of drug development, systems pharmacology, and infectious disease eradication.
Research Focus
Key Achievements
Top Papers
- 1